Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...

Independent investment company Breakthrough Victoria is investing $800,000 in Diag-Nose.io Medical (DNM), a Melbourne based ...

All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being ...

Eledon Pharmaceuticals has a promising anti-CD40L antibody for organ rejection prevention in transplantation. Learn more ...

For many polio patients, the iron lung was a bridge for survival, says Dr. Daniel Salerno, a pulmonary and critical ... agencies have made outstanding progress in administering polio vaccinations ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

As someone living with PH and coexisting conditions, columnist Jen Cueva has had to learn how to deal with frustrating health setbacks.

The primary objective of this trial is to evaluate the effect of cibotercept on pulmonary hemodynamics compared to placebo ... and for the treatment of cardiovascular disorders. Cautionary Note ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

Along with claiming the lives of 1.2 million Americans, the COVID-19 pandemic has been described as a mass disabling event.

Despite long COVID’s vast reach, and more than $1 billion spent on research, no new treatments have been brought to market.